South Micro Medicine disclosed that the 2022 semi -annual report achieved revenue of 960 million yuan

On August 18, Nanwei Medicine (code: 688029.SH) released the 2022 semi -annual performance report.

From January 1, 2022-June 30, 2022, the company realized operating income of 960 million yuan, an increase of 9.78%year-on-year, and net profit was 125 million yuan, a year-on-year decrease of 12.87%, and the basic earnings per share were 0.78 yuan.

The company's industry is a medical device.

During the company's reporting period, the total assets at the end of the period were 3.583 billion yuan, operating profit was 156 million yuan, accounts receivable was 305 million yuan, and the net cash flow generated by operating activities was 37.9868 million yuan.Cash is 1.096 billion yuan.

Nanwei Medicine, the company's full name Nanwei Medical Technology Co., Ltd., was established on May 10, 2000. The current general manager Leng Dezheng, the main business is the research and development, manufacturing and sales of minimally invasive medical devices.

- END -